Trials / Completed
CompletedNCT05653843
MANTIS Endoscopic Clipping Study
MANTIS Clip Study: A Prospective, Multi-Center, All-Comer MANTIS Endoscopic Clipping Study:
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 240 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is intended to document procedural and clinical effectiveness in consecutive cases in which at least one MANTIS clip is selected, pertaining to use of a new endoscopic clipping device MANTIS™ including but not limited to hemostasis, closure, anchoring and marking.
Detailed description
To document clinical effectiveness and safety when used per indication within the GI tract for the purpose of: 1. Endoscopic marking 2. Hemostasis for: * Mucosal/sub-mucosal defects \< 3 cm * Bleeding ulcers * Arteries \< 2 mm * Polyps \< 1.5 cm in diameter * Diverticula in the colon * Prophylactic clipping to reduce the risk of delayed bleeding post lesion resection 3. Anchoring to affix jejunal feeding tubes to the wall of the small bowel 4. As a supplementary method, closure of GI tract luminal perforations \< 20 mm that can be treated conservatively
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Endoscopic clip placement in the gastrointestinal tract. | The placement of a mechanical endoscopic clip in the gastrointestinal tract. |
Timeline
- Start date
- 2023-03-28
- Primary completion
- 2024-08-07
- Completion
- 2024-08-07
- First posted
- 2022-12-16
- Last updated
- 2025-08-12
- Results posted
- 2025-08-12
Locations
10 sites across 6 countries: United States, Canada, China, Hong Kong, India, Japan
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05653843. Inclusion in this directory is not an endorsement.